3B Pharmaceuticals GmbH is a pharmaceutical biotechnology company, a leader in the discovery and optimization of peptides for the development of tumor-targeted radiopharmaceuticals. Our aim is to treat and diagnose cancers that are currently difficult to address. 3BP’s expertise ranges from substance identification to early clinical development. The synthesis unit is a central element of 3B Pharmaceuticals, which is responsible for and has core competence in the production of research substances...